Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer

There is increasing interest in the use of cell-free circulating tumor DNA (ctDNA) as a serum marker for therapy assessment in prostate cancer patients. Prostate cancer is characterized by relatively low numbers of mutations, and, in contrast to many other common epithelial cancers, commercially ava...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Dis Markers
Главные авторы: Krumbholz, Manuela, Agaimy, Abbas, Stoehr, Robert, Burger, Maximilian, Wach, Sven, Taubert, Helge, Wullich, Bernd, Hartmann, Arndt, Metzler, Markus
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930771/
https://ncbi.nlm.nih.gov/pubmed/31915468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5085373
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы